Drilldown: Medicines
Appearance
Medicines > onset
:
30–60 min
or
Biochemical improvement within 2-4 weeks; full euthyroid state 6-12 weeks 
:
30–60 min
or
Biochemical improvement within 2-4 weeks; full euthyroid state 6-12 weeks 
Use the filters below to narrow your results.
Norepinephrine–dopamine reuptake inhibition (DAT, NET), d-threo enantiomer of methylphenidate (1) ·
Selective inhibitor of phosphodiesterase type 5 (PDE5), preventing cGMP breakdown in vascular smooth muscle. In the corpus cavernosum, potentiates the NO/cGMP cascade triggered by sexual stimulation. (1) ·
'"`UNIQ--vote-00000ECD-QINU`"' Agranulocytosis is the most-feared adverse effect (~0.3%, usually first 90 days of treatment; warn patients to seek urgent CBC for fever or severe sore throat). Hepatotoxicity is class-recognized but more often associated with PTU'"`UNIQ--ref-00000ECE-QINU`"'. (1)
Showing below up to 3 results in range #1 to #3.

